APG Asset Management N.V. Cuts Stock Position in The Clorox Company (NYSE:CLX)

APG Asset Management N.V. trimmed its position in shares of The Clorox Company (NYSE:CLX) by 58.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 31,700 shares of the company’s stock after selling 44,054 shares during the quarter. APG Asset Management N.V.’s holdings in Clorox were worth $4,036,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of CLX. J. W. Coons Advisors LLC acquired a new stake in Clorox in the fourth quarter valued at approximately $214,000. TFO Wealth Partners LLC increased its position in Clorox by 190,100.0% during the 4th quarter. TFO Wealth Partners LLC now owns 1,902 shares of the company’s stock valued at $271,000 after buying an additional 1,901 shares in the last quarter. Dorsey & Whitney Trust CO LLC purchased a new stake in Clorox in the fourth quarter valued at about $208,000. Scotia Capital Inc. acquired a new stake in Clorox in the fourth quarter worth about $466,000. Finally, California State Teachers Retirement System grew its stake in shares of Clorox by 4.9% during the fourth quarter. California State Teachers Retirement System now owns 202,034 shares of the company’s stock worth $28,808,000 after acquiring an additional 9,347 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Trading Up 0.9 %

CLX stock opened at $163.42 on Monday. The company has a quick ratio of 0.63, a current ratio of 1.03 and a debt-to-equity ratio of 5.04. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company’s 50-day simple moving average is $151.92 and its 200-day simple moving average is $143.96. The firm has a market cap of $20.29 billion, a P/E ratio of 84.67, a PEG ratio of 3.31 and a beta of 0.40.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. As a group, equities analysts forecast that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be given a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.99%. Clorox’s dividend payout ratio (DPR) is 252.85%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CLX. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. BNP Paribas raised Clorox to a “strong sell” rating in a research report on Friday, September 6th. Citigroup lifted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. TD Cowen started coverage on Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. Finally, Barclays lifted their target price on Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a report on Monday, August 5th. Six investment analysts have rated the stock with a sell rating and twelve have given a hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $143.33.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.51% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.